Article
125I brachytherapy as consolidative local therapy for patients with synchonous oligometastatic non-small cell lung cancer without progression after first-line chemotherapy plus PD-1 inhibitors treatment:A retrospective observational study
2023-11-14
Abstract excerpt
<h4>Purpose: </h4> The aim was to investigate the safety and efficacy of 125 I brachytherapy as consolidative local therapy for patients with synchonous oligometastatic non-small cell lung cancer (sOM-NSCLC) without progression after first-line chemotherapy plus PD-1 inhibitors treatment consolidative percutaneous. <h4>Materials: </h4> and Methods We retrospective analyzed 38 patients (31 male [81.6%], 7 women [1...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6d48a01c-adb8-57a6-87e2-782c4cd8ed7b
- DOI
- 10.21203/rs.3.rs-3575509/v1
